9606.HK
Duality Biotherapeutics, Inc.
1W: -11.1%
1M: -22.4%
3M: -10.8%
YTD: -20.6%
HK$256.00 ($32.74)
-7.20 (-2.74%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market CapHK$23.2B ($3.0B)
52W Range165.5-563.5
Volume781,235
Avg Volume736,438
Beta2.47
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOZhongyuan Zhu
Employees170
SectorHealthcare
IndustryBiotechnology
IPO Date2025-04-15
Websitedualitybiologics.com
Units 1103-1106, Building A, 868 Yinghua Road
Shanghai 201204
CN
Shanghai 201204
CN
86 (21) 2601 8730
About Duality Biotherapeutics, Inc.
Duality Biotherapeutics, Inc. operates as a clinical stage company. It focuses on the development of next generation antibody-drug conjugate therapeutics and duality immune toxin antibody conjugate therapeutic. The company was founded by Zhu Zhong Yuan on July 3, 2019 and is headquartered in Shanghai, China.
Recent Insider Trades
No insider trades found